Tumor suppressor p16 INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model.
about
Multivalent Carbohydrate-Lectin Interactions: How Synthetic Chemistry Enables Insights into Nanometric RecognitionFine-tuning of prototype chicken galectins: structure of CG-2 and structure-activity correlationsNatural single amino acid polymorphism (F19Y) in human galectin-8: detection of structural alterations and increased growth-regulatory activity on tumor cellsGalectin fingerprinting in naso-sinusal diseases.A regulatory network of two galectins mediates the earliest steps of avian limb skeletal morphogenesis.Galectins as tools for glycan mapping in histology: comparison of their binding profiles to the bovine zona pellucida by confocal laser scanning microscopy.Symmetric dithiodigalactoside: strategic combination of binding studies and detection of selectivity between a plant toxin and human lectins.Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides.Confirmation of translatability and functionality certifies the dual endothelin1/VEGFsp receptor (DEspR) protein.Pharmacological activation of estrogen receptors-α and -β differentially modulates keratinocyte differentiation with functional impact on wound healingGalectin-3 Induces a Pro-degradative/inflammatory Gene Signature in Human Chondrocytes, Teaming Up with Galectin-1 in Osteoarthritis Pathogenesis.Glycophenotyping of osteoarthritic cartilage and chondrocytes by RT-qPCR, mass spectrometry, histochemistry with plant/human lectins and lectin localization with a glycoproteinCarbohydrate-protein interactions: a 3D view by NMR.Beyond glycoproteins as galectin counterreceptors: tumor-effector T cell growth control via ganglioside GM1 [corrected].Biological applications of functionalized calixarenes.Context-dependent multifunctionality of galectin-1: a challenge for defining the lectin as therapeutic target.Multivalent glycocalixarenes for recognition of biological macromolecules: glycocalyx mimics capable of multitasking.The third dimension of reading the sugar code by lectins: design of glycoclusters with cyclic scaffolds as tools with the aim to define correlations between spatial presentation and activity.Introduction to glycopathology: the concept, the tools and the perspectivesGalectin-1 Couples Glycobiology to Inflammation in Osteoarthritis through the Activation of an NF-κB-Regulated Gene Network.Conformational selection in glycomimetics: human galectin-1 only recognizes syn-Ψ-type conformations of β-1,3-linked lactose and its C-glycosyl derivative.Lectins: getting familiar with translators of the sugar code.Cyclic neoglycodecapeptides: how to increase their inhibitory activity and selectivity on lectin/toxin binding to a glycoprotein and cells.Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptor α5β1-integrin.Sweet complementarity: the functional pairing of glycans with lectins.Comparative lectinology: Delineating glycan-specificity profiles of the chicken galectins using neoglycoconjugates in a cell assay.Open Wound Healing In Vivo: Monitoring Binding and Presence of Adhesion/Growth-Regulatory Galectins in Rat Skin during the Course of Complete Re-Epithelialization.Lipid glycosylation: a primer for histochemists and cell biologists.Galectins: their network and roles in immunity/tumor growth control.Ganglioside GM1/galectin-dependent growth regulation in human neuroblastoma cells: special properties of bivalent galectin-4 and significance of linker length for ligand selection.Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain.Regulatory Impact of Amniotic Membrane Transplantation on Presence of Adhesion/Growth-Regulatory Galectins-1 and -7 in Corneal Explants from Acanthamoeba Keratitis Patients: Clinical Note.Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR[Galectins, a class of unconventional lectins].Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancerContribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression.Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer.Loss of adhesion/growth-regulatory galectin-9 from squamous cell epithelium in head and neck carcinomas.Functional interplay between ganglioside GM1 and cross-linking galectin-1 induces axon-like neuritogenesis via integrin-based signaling and TRPC5-dependent Ca²⁺ influx.Clicked and long spaced galactosyl- and lactosylcalix[4]arenes: new multivalent galectin-3 ligands.
P2860
Q26749071-958E7F4A-180F-4264-ADBA-A57BF5226611Q27685442-8CC9B90F-644A-49DD-8036-38ECAF37FB34Q27688879-263043F8-8181-4298-9D0F-B084CF7C2B2BQ30436202-6F029DAF-EFEC-4D04-A6F5-C2B0B18A8887Q33810026-A75A6061-C423-4DE1-B745-5E9D7F27A9FBQ33902518-2F3FE411-5AF7-4427-9B4B-0CDE4F5F1A1EQ33928742-F0FBED30-4557-47BF-91B4-1B73EEF0F8F1Q35904166-CADC7D75-7731-4D3E-9CA7-490CF2B12F4DQ36052186-97678E1E-3C1E-4FF4-B857-81FEC89E517BQ36393989-78F0738F-1261-4D68-AB12-F7ABFDBECC05Q37508714-3B6219B7-E947-4A78-A833-EBEA79BA5E8BQ37690232-523028CC-C7E5-4A8F-9042-BBA31DBCB223Q37866236-41C7F17D-0423-4179-BC28-39DCE2DC63E9Q38004594-0AF6B615-C9DE-4254-ADEB-03424DCCC2E7Q38049083-7238D90F-A3B2-494A-9522-E1EEA7A134F1Q38071660-F73B70E9-925C-4591-8D69-975028F3A16FQ38077702-EBFC6026-F28A-4D4B-A4BA-9AE576CD82D3Q38096239-1B74B4DC-4B9E-49E1-B674-E17F06949CC0Q38180146-3C948CBD-7EA5-4922-8ADE-60361E8F761BQ38294225-03319E8E-0EFC-420D-B8B5-5A6759C574B0Q38312051-CF373100-4B0A-4008-B8D7-7F49089D2B1FQ38332609-E83168B2-34D5-4894-A963-711F50C8D2E9Q38337529-C5C2CFD8-0C99-409B-AF4E-D083C56F7E15Q38339024-E0135B29-DE0C-43A3-BCF3-8639ECD42D53Q38766179-E06165CD-4C3F-441D-962C-A939DE173271Q38909789-DA1D3361-0AA6-4643-A171-9586EC65F490Q38978059-AB417C32-05F8-494F-A3F0-0AA99EDC1394Q39045114-B3C7F1BD-634A-4213-9852-B3A1B8376A6EQ39052321-555C311E-54A2-4433-BABE-0A1EE72975B7Q39414217-3B04735E-3EAC-4913-82AD-0E66E2BFFA05Q40232517-DA2B0AA1-EF63-4F81-B830-0C51F2AAEA73Q41016662-83192AA2-428C-4017-8545-61431E1EEA0FQ41058851-E57D6D94-5C97-4330-A3B2-167569F4111AQ41172644-1A0423F3-AE9E-4750-AB28-FEFFF4817041Q41280263-32417542-AF3F-4B18-80B6-357C07B0214EQ41334598-C02B07D9-5604-4EA4-B326-53A06ACC0C34Q41387787-41E10BD6-C59C-4875-BBB8-D6A5004FF9A2Q42507266-5258218C-CB68-42EC-9507-7D8541260021Q42688469-6B37C2A1-3FE3-444F-88A5-EAEFDA0F840DQ42837584-2B6940FE-F634-4B02-A17E-BF99DBAF228B
P2860
Tumor suppressor p16 INK4a: Downregulation of galectin-3, an endogenous competitor of the pro-anoikis effector galectin-1, in a pancreatic carcinoma model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Tumor suppressor p16 INK4a: Do ...... a pancreatic carcinoma model.
@en
Tumor suppressor p16 INK4a: Do ...... a pancreatic carcinoma model.
@nl
type
label
Tumor suppressor p16 INK4a: Do ...... a pancreatic carcinoma model.
@en
Tumor suppressor p16 INK4a: Do ...... a pancreatic carcinoma model.
@nl
prefLabel
Tumor suppressor p16 INK4a: Do ...... a pancreatic carcinoma model.
@en
Tumor suppressor p16 INK4a: Do ...... a pancreatic carcinoma model.
@nl
P2093
P2860
P1433
P1476
Tumor suppressor p16 INK4a: Do ...... a pancreatic carcinoma model.
@en
P2093
Anja Wimmel
Christian Fischer
Hugo Sanchez-Ruderisch
Joachim C Manning
Katharina M Detjen
Martina Welzel
P2860
P304
P356
10.1111/J.1742-4658.2010.07764.X
P407
P577
2010-07-31T00:00:00Z